Abbott could restart infant formula production at Michigan plant in two weeks By Reuters

(Reuters) -Abbott Laboratories mentioned on Wednesday it might restart manufacturing of toddler components at its troubled Michigan facility inside two weeks.

The corporate in February recalled some child formulation, together with sure Similac merchandise, made on the plant in Sturgis after complaints about bacterial infections in infants who had consumed the merchandise.

Abbott will restart manufacturing of EleCare, Alimentum and metabolic formulation first, adopted by Similac and different manufacturers, after receiving the go-ahead from the U.S. Meals & Drug Administration (FDA).

As soon as manufacturing is resumed, it should take six to eight weeks earlier than the product returns to cabinets.

Abbott is the main provider of milk components in the USA and the recall has pushed a scarcity throughout the nation, forcing many main retailers to restrict purchases.

The FDA has mentioned it’s working with producers to alleviate provide points and that a number of corporations are at or over capability.